check_circleStudy Completed
Atrial Fibrillation
Bayer Identifier:
18732
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Real-world comparative effectiveness of Dabigatran versus Vitamin K antagonist
Trial purpose
To obtain a better understanding on the comparative effectiveness of dabigatran versus Vitamin K antagonist (VKA) for stroke prevention in patients with Non-valvular atrial fibrillation (NVAF) in a real-life setting.
Key Participants Requirements
Sex
BothAge
18 - N/ATrial summary
Enrollment Goal
56039Trial Dates
February 2016 - March 2016Phase
N/ACould I Receive a placebo
NoProducts
No DrugAccepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | New York, United States |
Primary Outcome
- Incidence of Hospitalization Events (composite endpoint)date_rangeTime Frame:Within 2 years of starting treatmentenhanced_encryptionYesSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A